Why Medication-Assisted Treatment Matters Behind Bars

Medication-assisted treatment, often called MAT, is one of the most important tools in modern addiction care. In Indiana, state health officials describe MAT as the combination of FDA-approved medication with counseling and cognitive behavioral therapy for opioid use disorder. That matters in jails and prisons because many people entering custody already have a substance use disorder, and withdrawal, relapse, and overdose risk can rise during and after incarceration.

For correctional systems, MAT is not just a medical issue. It is also a public safety issue, a reentry issue, and a continuity-of-care issue. When treatment starts in custody and continues after release, people may be better able to manage cravings, avoid overdose, and reconnect with community-based care.

How Indiana Defines MAT in Correctional Settings

Indiana's Department of Correction now has a 2026 Addiction Recovery Services policy that explicitly defines medication-assisted treatment as the use of FDA-approved medications that may be combined with counseling and behavioral interventions for substance use disorders. The same policy describes a broader continuum of care inside the department, including residential, intensive outpatient, and outpatient levels of treatment.

This is an important signal: Indiana is not treating addiction care in custody as a one-size-fits-all program. Instead, the state's correctional framework recognizes that people may need different levels of support depending on their clinical needs, custody status, and recovery goals.

What the State Is Doing in Prisons

Indiana's Department of Correction has a formal Addiction Recovery Services policy in effect as of March 1, 2026. That policy includes treatment planning, multidisciplinary care, and a recovery-oriented community model inside designated facilities. It also references purposeful incarceration, a joint initiative involving the department and the court system, which reflects Indiana's broader effort to connect treatment and justice system decision-making.

In practical terms, this means prison-based treatment in Indiana is being organized as part of a structured recovery system rather than as an isolated medical add-on. The policy also notes that treatment records are maintained in an approved electronic medical record and that staff are trained to recognize intoxication and overdose signs. Those details matter because correctional MAT programs depend on coordination, documentation, and safety protocols.

What the State Is Doing in Jails

Jails are often the first place where substance use disorder is identified, especially for people who have not been in treatment before. Indiana's criminal justice and public health materials show that jail-based treatment is part of the state's strategy. The Indiana Criminal Justice Institute's RSAT guidance says residential substance abuse treatment programs can be established in jails and prisons, and that jail-based programs should last at least three months and focus on the inmate's substance use problems.

That is significant because jail stays are often short. A jail MAT program has to do more than simply start medication; it has to connect people to follow-up care, release planning, and community treatment. Without that bridge, the benefits of treatment can be lost when someone leaves custody.

Why Continuity of Care Is the Real Test

The biggest challenge in correctional MAT is not only starting treatment, but continuing it. People leaving jail or prison face a high-risk period for overdose, especially if they have lost tolerance during incarceration. Indiana's public health resources emphasize that MAT reduces cravings and withdrawal symptoms and can lower overdose risk. But those benefits are strongest when treatment continues after release.

Indiana's recovery and justice materials also point to reentry services and community-based treatment. The state's Recovery Works initiative focuses on pre-incarceration diversion and post-incarceration reentry services, showing that Indiana sees recovery as a system that must extend beyond the jail door.

Which Medications Are Typically Used

In the United States, MAT for opioid use disorder commonly includes methadone, buprenorphine, and naltrexone. Indiana's public health pages and treatment guidance align with that national framework. These medications work differently, but the goal is similar: reduce withdrawal, reduce cravings, and support recovery.

In correctional settings, the choice of medication depends on clinical assessment, security considerations, available providers, and continuity planning. Indiana's opioid treatment program guidance says treatment programs use medically supervised medication-assisted treatment and pair medication with individual and group therapy. That model is especially relevant in custody, where treatment must be clinically sound and operationally manageable.

Indiana's Treatment Infrastructure Supports the Correctional Model

Indiana's public health system already has a statewide treatment infrastructure that correctional programs can connect to. The state lists opioid treatment programs and notes that, as of 2020, there were 18 OTPs in Indiana. The Division of Mental Health and Addiction also maintains an opioid treatment program directory and describes OTPs as outpatient providers offering medically supervised medication-assisted treatment.

That network matters because jails and prisons do not operate in isolation. A person who starts MAT in custody may need a community OTP, a primary care provider, or another behavioral health program after release. The stronger the local treatment network, the easier it is to maintain continuity.

What Indiana's Approach Gets Right

• It treats substance use disorder as a clinical condition, not just a disciplinary issue.
• It recognizes MAT as evidence-based care for opioid use disorder.
• It connects correctional treatment with reentry planning and community services.
• It supports multiple levels of care, which is important for people with different needs.
• It includes overdose awareness and staff training, which are essential in custody settings.

What Still Deserves Attention

Even with strong policy language, implementation is what determines whether MAT works in jails and prisons. Questions that matter include whether people can start medication quickly after intake, whether treatment is available in enough facilities, whether people can continue the same medication after transfer or release, and whether local jails have the staffing and referral networks to support follow-up care.

Another important issue is access. Not every jail or prison can offer the same services, and Indiana's own policy acknowledges treatment limitations may exist at some facilities. That means the quality of MAT can vary depending on location, custody status, and available clinical resources.

The Bottom Line for Indiana

As of today, Indiana is clearly moving toward a more integrated correctional treatment model. The state's correctional policy defines MAT, its public health agencies promote MAT as effective treatment for opioid use disorder, and its criminal justice programs encourage substance abuse treatment in jails and prisons with aftercare and reentry support. The direction is promising, but the real measure of success will be whether people in custody can access timely, consistent, and medically appropriate treatment before release and after they return to the community.

For Indiana, medication-assisted treatment in jails and prisons is no longer a fringe idea. It is part of the state's broader strategy to reduce overdose risk, support recovery, and improve public safety through evidence-based care.

Other Relevant Articles for Indiana

Relevant County Info

Information is sourced from publicaly available information and may be inaccurate